Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

Addition of hormone therapy to radiotherapy treatments improves survival in prostate cancer patients

Addition of hormone therapy to radiotherapy treatments improves survival in prostate cancer patients

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

Researchers implement and evaluate an educational intervention for prostate cancer

Researchers implement and evaluate an educational intervention for prostate cancer

Study shows AI systems can accurately identify and grade prostate cancer

Study shows AI systems can accurately identify and grade prostate cancer

New trial could transform the way of caring for people with neuroendocrine tumors

New trial could transform the way of caring for people with neuroendocrine tumors

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Long-excluded uterine cancer patients are step closer to 9/11 benefits

MAPK4 may play a key role in triple-negative breast cancer

MAPK4 may play a key role in triple-negative breast cancer

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

The war on cancer at 50: The origin story begins with a socialite citizen-lobbyist

The war on cancer at 50: The origin story begins with a socialite citizen-lobbyist

Black men with prostate cancer may have improved response to radiation therapy than white men

Black men with prostate cancer may have improved response to radiation therapy than white men

Researchers identify novel cancer markers in patients with aggressive prostate cancer

Researchers identify novel cancer markers in patients with aggressive prostate cancer

A Day in the Life of A Clinical Geneticist

A Day in the Life of A Clinical Geneticist

The Ronald Weiser Center for Prostate Cancer to be established with $30 million gift

The Ronald Weiser Center for Prostate Cancer to be established with $30 million gift

Novel technique developed to observe cancer cells’ metastatic potential

Novel technique developed to observe cancer cells’ metastatic potential

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

Henry Ford surgeons use unique approach to perform first precision prostatectomy

Henry Ford surgeons use unique approach to perform first precision prostatectomy

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

TP53 mutations in men may predispose to aggressive prostate cancer

TP53 mutations in men may predispose to aggressive prostate cancer

Stand Up To Cancer - An Interview with Chris Draft

Stand Up To Cancer - An Interview with Chris Draft

COVID-19 pandemic likely caused new cancer diagnoses to be delayed, study shows

COVID-19 pandemic likely caused new cancer diagnoses to be delayed, study shows